Exploratory Cardiac Endpoint Data from APOLLO Published in Circulation

Exploratory Cardiac Endpoint Data from APOLLO Published in Circulation

Data from exploratory cardiac assessments and post-hoc analyses of safety data in the APOLLO Phase 3 study of patisiran, an RNAi therapeutic for the treatment of the polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis in adults, were published in the journal Circulation.

Read the paper in Circulation



SIGN UP FOR EMAIL UPDATES

Receive news and updates on the work at Alnylam that affects you most.